Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
BOONE-GIELEN INVEST from Kasterlee, company number BE0884462529, closed financial year 2025 with a result of € 172,908 after tax. For that financial year BOONE-GIELEN INVEST recorded a gross margin of € 325,787 and equity of € 2.7 million. Compared with financial year 2024, the result moved from € 189,320 to € 172,908. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 5, 2026.
€ 2.7 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 172,908
▼ 9% vs 2024
Profit after tax over the fiscal year.
€ 230,062
▲ € 193,718 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2 million.
People and assets in 2025
0.5
Average over the fiscal year, from the social balance sheet.
€ 8,472
▼ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 55,313
▲ € 54,705 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.1 million
▼ 7% vs 2024
€ 136,747 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 48,057
▲ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 27,580
▲ 27% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 349,038 | € 343,663 | € 338,109 | € 325,787 | ▼ 4% |
| Profit after taxes | € 230,980 | € 187,500 | € 189,320 | € 172,908 | ▼ 9% |
| Equity | € 2,101,255 | € 2,288,755 | € 2,478,075 | € 2,650,983 | ▲ 7% |
| Total debts | € 2,489,349 | € 2,537,458 | € 2,493,055 | € 2,900,076 | ▲ 16% |
| Cash | € 21,820 | € 16,433 | € 36,344 | € 230,062 | ▲ € 193,718 |
| Land & buildings | € 498,118 | € 747,757 | € 905,885 | € 883,065 | ▼ 3% |
| Retained profit | € 1,451,255 | € 1,638,755 | € 1,828,075 | € 2,000,983 | ▲ 9% |
| Bank debt | € 1,358,354 | € 1,310,000 | € 1,144,703 | € 1,065,984 | ▼ 7% |
| Balance sheet total | € 4,590,604 | € 4,826,213 | € 4,971,131 | € 5,551,059 | ▲ 12% |
| Employees (FTE) | 0.1 | 6.5 | 0.5 | 0.5 |
Key figures of BOONE-GIELEN INVEST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to BOONE-GIELEN INVEST?
What happened at BOONE-GIELEN INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Boone-Gielen Consult BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 172,908 (▼ 9% vs 2024). Source: NBB ↗
- Boone-Gielen Consult BV became a director. NBB
- New establishment in Kasterlee. KBO
- Start of the company according to the CBE. KBO
In short
From € 230,980 profit in 2022 to € 172,908 profit in 2025.
Paid € 265,728 in corporate taxes since 2022.
Best year ever: 2022, with € 230,980 profit.
On average € 52,900 of value added per employee in 2023.
A new publication or filing at BOONE-GIELEN INVEST? We notify you, reason included.
Follow BOONE-GIELEN INVESTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BOONE-GIELEN CONSULT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BOONE-GIELEN INVESTThe shares are held by BOONE-GIELEN CONSULT (0.5%). It owns 100% of Queens Apotheek, 100% of Apotheek Healthcorner, 100% of Huvefar, 99.5% of Apotheek Put and 99.5% of Yobera itself.
Directors
According to the 2025 annual accounts
Director · represented by Guido Boone
since 2020 · until 2026
Shareholders
0.5%
Participations
Establishments
Establishment units
Physical locations of this company
Isschot 24
2460 Kasterlee
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0884.462.529
- VAT number
- BE 0884.462.529
- Registered office
- Isschot 24, 2460 Kasterlee
- Names & denominations
- BOONE-GIELEN INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 October 2006
- Peppol
- Active · Active since 5 Feb 2026
- Activities · NACE
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings
Diverse ondersteunende activiteiten ten behoeve van voorzieningen
Beheer van residentiële gebouwen